← Eichor
Study identifier: NCT07081152 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Iron Absorption and Losses in Young South African Women Living Without and With Overweight and Obesity

Condition: Obesity · Iron Deficiency · Inflammation  ·  Sponsor: Linda Malan

PhaseNA
Planned participants70
Who can joinFemale, 18 Years to 35 Years
Healthy volunteersYes

About this study

Young women living with obesity (OB) have a greater risk of developing iron deficiency. Plus, the risk of anemia and/or ID in young women living with overweight (OW) and obesity (OB) is further increased by inadequate dietary intake and/or poor bioavailability of iron, as well as gastrointestinal and menstrual iron losses. It is not certain whether women living with OW/OB can meet their iron requirements from their day-to-day diet. The aim of this study is to compare iron absorption and losses over a long period between women living with and without OW and OB. Secondary outcomes include iron and inflammation status, as well as dietary iron intake.

This description comes directly from the study's public registry record.

Talk to the study team

Mary Uyoga, PhD  ·  +27 18 299 4237  ·  44645104@mynwu.ac.za

Linda Malan, PhD  ·  +27 18 299 4237  ·  Linda.Malan@nwu.ac.za

Always discuss trial participation with your own doctor first.

Locations (1)

Esté Vorster Research FacilityPotchefstroom, North West, South AfricaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07081152